A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer
暂无分享,去创建一个
S. Park | Yoon-Koo Kang | Yeul-Hong Kim | D. Sakai | H. Chung | A. Yamamura | V. Wacheck | D. Oh | S. Wijayawardana | T. Doi | Xuejing Wang | Y. Komatsu | A. Tsuji | K. Uenaka | S. Kadowaki